» Articles » PMID: 27496732

The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

Overview
Journal Immunity
Publisher Cell Press
Date 2016 Aug 7
PMID 27496732
Citations 392
Authors
Affiliations
Soon will be listed here.
Abstract

Although tumor-specific T cells recognize cancer cells, they are often rendered dysfunctional due to an immunosuppressive microenvironment. Here we showed that T cells demonstrated persistent loss of mitochondrial function and mass when infiltrating murine and human tumors, an effect specific to the tumor microenvironment and not merely caused by activation. Tumor-infiltrating T cells showed a progressive loss of PPAR-gamma coactivator 1α (PGC1α), which programs mitochondrial biogenesis, induced by chronic Akt signaling in tumor-specific T cells. Reprogramming tumor-specific T cells through enforced expression of PGC1α resulted in superior intratumoral metabolic and effector function. Our data support a model in which signals in the tumor microenvironment repress T cell oxidative metabolism, resulting in effector cells with metabolic needs that cannot be met. Our studies also suggest that modulation or reprogramming of the altered metabolism of tumor-infiltrating T cells might represent a potential strategy to reinvigorate dysfunctional T cells for cancer treatment.

Citing Articles

The Emerging Role of CD8 T Cells in Shaping Treatment Outcomes of Patients with MDS and AML.

Tasis A, Spyropoulos T, Mitroulis I Cancers (Basel). 2025; 17(5).

PMID: 40075597 PMC: 11898900. DOI: 10.3390/cancers17050749.


Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemia.

Jacobs C, Peters F, Camerini E, Cretenet G, Rietveld J, Schomakers B Cell Mol Immunol. 2025; .

PMID: 40033083 DOI: 10.1038/s41423-025-01262-1.


How modulation of the tumor microenvironment drives cancer immune escape dynamics.

Shrestha P, Ghoreyshi Z, George J Sci Rep. 2025; 15(1):7308.

PMID: 40025156 PMC: 11873109. DOI: 10.1038/s41598-025-91396-z.


Energy metabolism in health and diseases.

Liu H, Wang S, Wang J, Guo X, Song Y, Fu K Signal Transduct Target Ther. 2025; 10(1):69.

PMID: 39966374 PMC: 11836267. DOI: 10.1038/s41392-025-02141-x.


Metabolic heterogeneity in tumor cells impacts immunology in lung squamous cell carcinoma.

Wang Q, Sun N, Zhang C, Kunzke T, Zens P, Feuchtinger A Oncoimmunology. 2025; 14(1):2457797.

PMID: 39924768 PMC: 11812363. DOI: 10.1080/2162402X.2025.2457797.


References
1.
Xiao B, Deng X, Zhou W, Tan E . Flow Cytometry-Based Assessment of Mitophagy Using MitoTracker. Front Cell Neurosci. 2016; 10:76. PMC: 4811937. DOI: 10.3389/fncel.2016.00076. View

2.
Crompton J, Sukumar M, Roychoudhuri R, Clever D, Gros A, Eil R . Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 2014; 75(2):296-305. PMC: 4384335. DOI: 10.1158/0008-5472.CAN-14-2277. View

3.
Roos D, LOOS J . Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin. Biochim Biophys Acta. 1970; 222(3):565-82. DOI: 10.1016/0304-4165(70)90182-0. View

4.
Pearce E, Poffenberger M, Chang C, Jones R . Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013; 342(6155):1242454. PMC: 4486656. DOI: 10.1126/science.1242454. View

5.
Sukumar M, Liu J, Mehta G, Patel S, Roychoudhuri R, Crompton J . Mitochondrial Membrane Potential Identifies Cells with Enhanced Stemness for Cellular Therapy. Cell Metab. 2015; 23(1):63-76. PMC: 4747432. DOI: 10.1016/j.cmet.2015.11.002. View